EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 60 filers reported holding EPIZYME INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $20,929,000 | +23.0% | 1,729,674 | 0.0% | 9.88% | +77.2% |
Q3 2016 | $17,020,000 | -3.9% | 1,729,674 | 0.0% | 5.58% | -3.0% |
Q2 2016 | $17,712,000 | -15.5% | 1,729,674 | 0.0% | 5.74% | -11.6% |
Q1 2016 | $20,964,000 | -24.3% | 1,729,674 | 0.0% | 6.50% | +31.4% |
Q4 2015 | $27,709,000 | +24.6% | 1,729,674 | 0.0% | 4.94% | +44.5% |
Q3 2015 | $22,244,000 | -48.0% | 1,729,674 | -2.9% | 3.42% | -52.2% |
Q2 2015 | $42,746,000 | +5.2% | 1,781,086 | -17.7% | 7.15% | -17.5% |
Q1 2015 | $40,637,000 | -10.8% | 2,163,819 | -10.4% | 8.67% | -14.3% |
Q4 2014 | $45,549,000 | -30.4% | 2,413,819 | 0.0% | 10.12% | -52.8% |
Q3 2014 | $65,439,000 | -12.9% | 2,413,819 | 0.0% | 21.42% | -15.3% |
Q2 2014 | $75,118,000 | +36.7% | 2,413,819 | 0.0% | 25.27% | +8.6% |
Q1 2014 | $54,963,000 | -8.3% | 2,413,819 | -16.2% | 23.26% | +20.2% |
Q4 2013 | $59,914,000 | -48.0% | 2,880,485 | 0.0% | 19.35% | -40.4% |
Q3 2013 | $115,219,000 | +42.2% | 2,880,485 | 0.0% | 32.49% | -9.4% |
Q2 2013 | $81,028,000 | – | 2,880,485 | – | 35.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,488,444 | $18,680,000 | 10.50% |
Opaleye Management Inc. | 1,365,000 | $17,131,000 | 5.22% |
Palo Alto Investors LP | 6,935,074 | $87,035,000 | 4.23% |
Consonance Capital Management LP | 4,760,059 | $59,739,000 | 4.23% |
Foresite Capital Management III, LLC | 998,278 | $12,528,000 | 4.11% |
NEA Management Company, LLC | 4,377,518 | $54,938,000 | 3.85% |
Redmile Group, LLC | 8,729,142 | $109,551,000 | 3.10% |
Diametric Capital, LP | 156,575 | $1,965,000 | 1.25% |
Ghost Tree Capital, LLC | 465,000 | $5,836,000 | 1.21% |
Opus Point Partners Management, LLC | 50,378 | $632,000 | 0.94% |